General Information of Drug (ID: DMTUK2E)

Drug Name
AVT001
Indication
Disease Entry ICD 11 Status REF
Type-1 diabetes 5A10 Phase 1/2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
DD52FT

References

1 ClinicalTrials.gov (NCT03895996) A Phase 1 / 2 Double-Blind, Randomized, Placebo Controlled Study of Safety, Tolerability and Potential Efficacy of AVOTRES Cell-Based Therapy (AVT001) in Patients With Type 1 Diabetes. U.S.National Institutes of Health.